Finally, we noted that combination vaccines that incorporate both the CKM and anti-PD-L1 antibody yielded the greatest therapeutic benefit in association with epitope spreading and the highest levels of multifunctional CD8+ TIL with reduced Treg/MDSC regulatory cell content in the tumor microenvironment (TME). The gene discussed is CKM; the disease is neoplasm.